Everyone is asking the question, when will the vaccine come to Nepal? We tried to find the answer from Dr. Suresh Tiwari, a public health expert, and Dr. Jageshwor Gautam, Spokesperson, Ministry of Health and Population, but unfortunately, they were not available for comment. We did talk to Dr. Prakash …
Read More »CHINA’S VACCINE STORY
China has been among the first in the world to effectively stop the spread of SARS-CoV-2 in the country, and because of this, the government has been able to take its time over the development of a vaccine. This is in contrast to Western and other nations, where the development …
Read More »COVID-19 Vaccine Distribution in the USA
In the United States, President Trump launched Operation Warp Speed in May 2020 to fast-track development, testing, regulatory approval, and distribution of COVID-19 vaccines. The U.S. has booked hundreds of millions of doses of vaccine candidates in advance, and at least the initial vaccinations will be available to all Americans …
Read More »COVID-19 VACCINE DEVELOPMENT
CanSino Biologics CanSino Biologics’ vaccine is a one-dose adenovirus-based vaccine that can be stored at 2–8 ºC. Its trial included 40,000 volunteers. March 2020: China’s CanSino Biologics and the Academy of Military Medical Sciences launch phase 1 trial in Wuhan after getting regulatory approval to start human trials of their …
Read More »Woes of Pfizer-BioNTech COVID-19 Vaccine
Woes of Pfizer-BioNTech COVID-19 Vaccine On December 16, The New York Times reported serious allergic reactions in two health workers in Alaska after getting the Pfizer-BioNTech’s COVID-19 vaccine. The first worker, a middle-aged woman, experienced a rash over her face and body, shortness of breath, and elevated heart rate 10 …
Read More »Serum Institute to make 100 million doses of Covishield every month
Serum Institute to make 100 million doses of Covishield every month Starting next year, the world’s largest vaccine manufacturer, Serum Institute of India, is planning to make up to 100 million doses of AstraZeneca-Oxford’s COVID-19 vaccine each month, Named Covishield, the vaccine is undergoing phase 3 trials in India, and …
Read More »FDA Commissioner Grants EUA to Pfizer Vaccine
FDA Commissioner Grants EUA to Pfizer Vaccine Pfizer’s COVID-19 vaccine has been granted emergency use authorization (EUA) by the US FDA. The New York Times, referring to an anonymous authoritative source, reports that FDA Commissioner Dr. Stephen Hahn was under immense pressure from President Trump to allow EUA for the …
Read More »Roche’s SARS-CoV-2 antibody test included in Moderna vaccine trials
Roche’s SARS-CoV-2 antibody test included in Moderna vaccine trials After receiving US FDA emergency use authorization for its Elecsys® Anti-SARS-CoV-2 antibody test on November 25, 2020, Roche has partnered with Moderna to utilize the test in the latter’s mRNA-1273 vaccine research trials. The antibody test measures the quantity of antibodies …
Read More »THE VACCINES ARE HERE
According to The New York Times’ “Corona Vaccine Tracker”, till Nov 17, 2020, there are 54 vaccines in clinical trials on humans, and at least 87 preclinical vaccines that are under active investigation in animals. Till date, 38 potential vaccines for COVID-19 are undergoing Phase 1 trials (safety and …
Read More »Now this! Siberian Vaccine Claims 100% Efficacy
Siberia’s Vector Research Center has claimed that all volunteers vaccinated by its COVID-19 vaccine, EpiVacCorona, developed antibodies, although the first two phases of testing involved only 100 volunteers. The center reported, “Clinical studies have shown that antibodies were detected in 100% of the volunteers immunized with the EpiVacCorona vaccine, Most …
Read More »